|
|
|
|
LEADER |
02467nam a2200517 u 4500 |
001 |
EB001843149 |
003 |
EBX01000000000000001007138 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
180730 r ||| eng |
020 |
|
|
|z 0833085492
|
020 |
|
|
|a 0833085492
|
020 |
|
|
|z 9780833085498
|
020 |
|
|
|a 9780833085498
|
050 |
|
4 |
|a RA395.A3
|
100 |
1 |
|
|a Garber, Steven
|
245 |
0 |
0 |
|a Redirecting innovation in U.S. health care
|h Elektronische Ressource
|b options to decrease spending and increase value
|c Steven Garber [and others]
|
260 |
|
|
|a Santa Monica
|b RAND Corporation
|c 2014©2014, 2014
|
300 |
|
|
|a xxvii, 105 pages
|b illustrations
|
505 |
0 |
|
|a Introduction -- The context for medical product innovation -- Methods -- Analysis -- Policy options to improve the U.S. medical product innovation system -- In conclusion -- Appendix A: Cost-effectiveness and value -- Appendix B: An economic model of innovation
|
505 |
0 |
|
|a Includes bibliographical references (pages 91-105)
|
651 |
|
4 |
|a United States / fast
|
653 |
|
|
|a Medical care
|
653 |
|
|
|a Cost effectiveness
|
653 |
|
|
|a Medical innovations
|
653 |
|
|
|a MEDICAL / Allied Health Services / Medical Technology
|
653 |
|
|
|a Medical policy
|
653 |
|
|
|a Biomedical engineering
|
653 |
|
|
|a POLITICAL SCIENCE / Public Policy / Social Security
|
653 |
|
|
|a Medical care, Cost of
|
653 |
|
|
|a POLITICAL SCIENCE / Public Policy / Social Services & Welfare
|
653 |
|
|
|a Medical care / United States
|
700 |
1 |
|
|a Gates, Susan M.
|
700 |
1 |
|
|a Keeler, Emmett B.
|
700 |
1 |
|
|a Vaiana, Mary E.
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b ZDB-39-JOA
|a JSTOR Open Access Books
|
490 |
0 |
|
|a RAND Corporation research report series
|
500 |
|
|
|a "RR-308"--Page 4 of cover
|
024 |
8 |
|
|a RAND/RR-308
|
773 |
0 |
|
|t Books at JSTOR: Open Access
|
776 |
|
|
|z 9780833085474
|
776 |
|
|
|z 0833085476
|
856 |
4 |
0 |
|u https://www.jstor.org/stable/10.7249/j.ctt6wq8jv
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 362.10973
|
520 |
|
|
|a New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases
|